#innovation

CNBC’s Becky Quick to Moderate High-Level CEO Panel on Rare Disease Innovation at the 2026 NORD Breakthrough Summit

CNBC’s Becky Quick to Moderate High-Level CEO Panel on Rare Disease Innovation at the 2026 NORD Breakthrough Summit

WASHINGTON, D.C. and NORWELL, Mass. — The National Organization for Rare Diseases (NORD®) has announced a prominent addition...

BioMarin, Jazz Pharmaceuticals, and Otsuka CEOs to Join NORD CEO for High-Level Dialogue on Transforming Scientific Innovation Into Patient Progress

BioMarin, Jazz Pharmaceuticals, and Otsuka CEOs to Join NORD CEO for High-Level Dialogue on Transforming Scientific Innovation Into Patient Progress

WASHINGTON, D.C. and NORWELL, Mass. — The National Organization for Rare Disorders (NORD®) has announced that CNBC “Squawk...

BioMarin, Jazz Pharmaceuticals, and Otsuka CEOs to Join NORD CEO for High-Level Dialogue on Rare Disease Innovation

BioMarin, Jazz Pharmaceuticals, and Otsuka CEOs to Join NORD CEO for High-Level Dialogue on Rare Disease Innovation

WASHINGTON, D.C. and NORWELL, Mass. — In an era defined by unprecedented scientific breakthroughs, the ultimate measure of...

CNBC’s Becky Quick to Moderate High-Level CEO Panel on the Future of Rare Disease Innovation at NORD’s 2026 Breakthrough Summit

WASHINGTON, D.C. and NORWELL, Mass. — The National Organization for Rare Diseases (NORD®) has announced that CNBC “Squawk Box” co-anchor...

Becky Quick to Moderate High-Level CEO Panel on the Future of Rare Disease Innovation at the 2026 NORD Breakthrough Summit

WASHINGTON, D.C. and NORWELL, Mass. — The National Organization for Rare Diseases (NORD®) has announced a prominent leadership lineup for...

Industry Leaders to Convene at NORD Summit to Tackle the Future of Rare Disease Innovation

WASHINGTON, D.C. and NORWELL, Mass. — As scientific breakthroughs open unprecedented possibilities for diagnosing and treating rare conditions, turning those...

Industry Leaders to Tackle the Future of Rare Disease Innovation at the 2026 NORD Breakthrough Summit

WASHINGTON, D.C. and NORWELL, Mass. — The National Organization for Rare Diseases (NORD®) has announced a high-profile leadership dialogue for...

Lived-Experience Innovation: How Spynergie Boutique Is Addressing the Overlooked Logistical Challenges of Wheelchair Travel

Traveling with a manual or power wheelchair requires a degree of logistical foresight that standard travel itineraries rarely account for....